430 related articles for article (PubMed ID: 23077594)
21. Specificity of the tuberculin skin test and the T-SPOT.TB assay among students in a low-tuberculosis incidence setting.
Talbot EA; Harland D; Wieland-Alter W; Burrer S; Adams LV
J Am Coll Health; 2012; 60(1):94-6. PubMed ID: 22171735
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of gamma interferon release assays using Mycobacterium tuberculosis antigens for diagnosis of latent and active tuberculosis in Mycobacterium bovis BCG-vaccinated populations.
Zhang S; Shao L; Mo L; Chen J; Wang F; Meng C; Zhong M; Qiu L; Wu M; Weng X; Zhang W
Clin Vaccine Immunol; 2010 Dec; 17(12):1985-90. PubMed ID: 20943878
[TBL] [Abstract][Full Text] [Related]
23. T-Spot.TB outperforms tuberculin skin test in predicting development of active tuberculosis among household contacts.
Leung CC; Yam WC; Ho PL; Yew WW; Chan CK; Law WS; Lee SN; Chang KC; Tai LB; Tam CM
Respirology; 2015 Apr; 20(3):496-503. PubMed ID: 25689894
[TBL] [Abstract][Full Text] [Related]
24. Screening for latent tuberculosis in Norwegian health care workers: high frequency of discordant tuberculin skin test positive and interferon-gamma release assay negative results.
Gran G; Aßmus J; Dyrhol-Riise AM
BMC Public Health; 2013 Apr; 13():353. PubMed ID: 23590619
[TBL] [Abstract][Full Text] [Related]
25. Prognostic value of interferon-γ release assays and tuberculin skin test in predicting the development of active tuberculosis (UK PREDICT TB): a prospective cohort study.
Abubakar I; Drobniewski F; Southern J; Sitch AJ; Jackson C; Lipman M; Deeks JJ; Griffiths C; Bothamley G; Lynn W; Burgess H; Mann B; Imran A; Sridhar S; Tsou CY; Nikolayevskyy V; Rees-Roberts M; Whitworth H; Kon OM; Haldar P; Kunst H; Anderson S; Hayward A; Watson JM; Milburn H; Lalvani A;
Lancet Infect Dis; 2018 Oct; 18(10):1077-1087. PubMed ID: 30174209
[TBL] [Abstract][Full Text] [Related]
26. [Interferon-gamma assays T-SPOT.TB for the diagnosis of latent tuberculosis infection].
Borkowska D; Zwolska Z; Michałowska-Mitczuk D; Korzeniewska-Koseła M; Zabost A; Napiórkowska A; Kozińska M; Brzezińska S; Augustynowicz-Kopeć E
Pneumonol Alergol Pol; 2011; 79(4):264-71. PubMed ID: 21678276
[TBL] [Abstract][Full Text] [Related]
27. Interferon-γ release assays for diagnosis of tuberculosis infection and disease in children.
Starke JR;
Pediatrics; 2014 Dec; 134(6):e1763-73. PubMed ID: 25422024
[TBL] [Abstract][Full Text] [Related]
28. The impact of BCG vaccination on tuberculin skin test responses in children is age dependent: evidence to be considered when screening children for tuberculosis infection.
Seddon JA; Paton J; Nademi Z; Keane D; Williams B; Williams A; Welch SB; Liebeschutz S; Riddell A; Bernatoniene J; Patel S; Martinez-Alier N; McMaster P; Kampmann B
Thorax; 2016 Oct; 71(10):932-9. PubMed ID: 27335104
[TBL] [Abstract][Full Text] [Related]
29. The performance of quantiferon-TB gold in-tube (QFT-IT) test compared to tuberculin skin test (TST) in detecting latent tuberculosis infection (LTBI) in the presence of HIV coinfection in a high TB-burden area with BCG-vaccinated population.
James PM; Ganaie FA; Kadahalli RL
J Int Assoc Provid AIDS Care; 2014; 13(1):47-55. PubMed ID: 23482341
[TBL] [Abstract][Full Text] [Related]
30. Improved sensitivity of an interferon-gamma release assay (T-SPOT.TB™) in combination with tuberculin skin test for the diagnosis of latent tuberculosis in the presence of HIV co-infection.
Elzi L; Steffen I; Furrer H; Fehr J; Cavassini M; Hirschel B; Hoffmann M; Bernasconi E; Bassetti S; Battegay M
BMC Infect Dis; 2011 Nov; 11():319. PubMed ID: 22085801
[TBL] [Abstract][Full Text] [Related]
31. Is the T-cell-based interferon-gamma releasing assay feasible for diagnosis of latent tuberculosis infection in an intermediate tuberculosis-burden country?
Dilektasli AG; Erdem E; Durukan E; Eyüboğlu FÖ
Jpn J Infect Dis; 2010 Nov; 63(6):433-6. PubMed ID: 21099095
[TBL] [Abstract][Full Text] [Related]
32. Interferon-γ release assay as a sensitive diagnostic tool of latent tuberculosis infection in patients with HIV: a cross-sectional study.
Klautau GB; da Mota NVF; Salles MJC; Burattini MN; Rodrigues DS
BMC Infect Dis; 2018 Nov; 18(1):585. PubMed ID: 30453903
[TBL] [Abstract][Full Text] [Related]
33. Prevalence of tuberculosis in migrant children in Switzerland and relevance of current screening guidelines.
Boukamel M; Fougère Y; Gehri M; Suris JC; Rochat I; Miletto D; Kyrilli S; Fouriki A; Crisinel PA
Swiss Med Wkly; 2020 Jun; 150():w20253. PubMed ID: 32557426
[TBL] [Abstract][Full Text] [Related]
34. Contribution of interferon gamma release assays testing to the diagnosis of latent tuberculosis infection in HIV-infected patients: a comparison of QuantiFERON-TB Gold In Tube, T-SPOT.TB and tuberculin skin test.
Ramos JM; Robledano C; Masiá M; Belda S; Padilla S; Rodríguez JC; Gutierrez F
BMC Infect Dis; 2012 Jul; 12():169. PubMed ID: 22849726
[TBL] [Abstract][Full Text] [Related]
35. Agreement between QuantiFERON®-TB Gold In-Tube and the tuberculin skin test and predictors of positive test results in Warao Amerindian pediatric tuberculosis contacts.
Verhagen LM; Maes M; Villalba JA; d'Alessandro A; Rodriguez LP; España MF; Hermans PW; de Waard JH
BMC Infect Dis; 2014 Jul; 14():383. PubMed ID: 25012075
[TBL] [Abstract][Full Text] [Related]
36. Relation between BCG vaccine scar and an interferon-gamma release assay in immigrant children with "positive" tuberculin skin test (≥10 mm).
Gudjónsdóttir MJ; Kötz K; Nielsen RS; Wilmar P; Olausson S; Wallmyr D; Trollfors B
BMC Infect Dis; 2016 Oct; 16(1):540. PubMed ID: 27716176
[TBL] [Abstract][Full Text] [Related]
37. The diagnostic performance of novel skin-based in-vivo tests for tuberculosis infection compared with purified protein derivative tuberculin skin tests and blood-based in vitro interferon-γ release assays: a systematic review and meta-analysis.
Krutikov M; Faust L; Nikolayevskyy V; Hamada Y; Gupta RK; Cirillo D; Mateelli A; Korobitsyn A; Denkinger CM; Rangaka MX
Lancet Infect Dis; 2022 Feb; 22(2):250-264. PubMed ID: 34606768
[TBL] [Abstract][Full Text] [Related]
38. Comparative performance of tuberculin skin test, QuantiFERON-TB-Gold In Tube assay, and T-Spot.TB test in contact investigations for tuberculosis.
Diel R; Loddenkemper R; Meywald-Walter K; Gottschalk R; Nienhaus A
Chest; 2009 Apr; 135(4):1010-1018. PubMed ID: 19017873
[TBL] [Abstract][Full Text] [Related]
39. High-sensitive and rapid detection of Mycobacterium tuberculosis infection by IFN-gamma release assay among HIV-infected individuals in BCG-vaccinated area.
Jiang W; Shao L; Zhang Y; Zhang S; Meng C; Xu Y; Huang L; Wang Y; Wang Y; Weng X; Zhang W
BMC Immunol; 2009 May; 10():31. PubMed ID: 19476627
[TBL] [Abstract][Full Text] [Related]
40. Combined use of a TST and the T-SPOT®.TB assay for latent tuberculosis infection diagnosis before anti-TNF-α treatment.
Jung YJ; Lyu J; Yoo B; Lee CK; Kim YG; Yang SK; Byeon JS; Kim KJ; Ye BD; Lee KH; Lee SD; Kim WS; Kim DS; Shim TS
Int J Tuberc Lung Dis; 2012 Oct; 16(10):1300-6. PubMed ID: 22863375
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
